MedPath
NMPA Approval

Capivasertib Tablets

国药准字HJ20250046

April 15, 2025

Drug Information

卡匹色替片

荃科得

片剂

160mg

化学药品

April 15, 2025

April 14, 2030

Company Information

Applicant Company

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, United Kingdom

Manufacturing Company

ASTRAZENECA AB

Gärtunavägen, Södertälje, 152 57, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

卡匹色替片 - NMPA 批准文号 | MedPath